Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127027181 | 12702718 | 1 | I | 20160824 | 20160831 | 20160831 | EXP | US-PFIZER INC-2016405303 | PFIZER | 0.00 | M | Y | 0.00000 | 20160831 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127027181 | 12702718 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | UNK UNK, 2X/DAY(EITHER 300 OR 600 MG TWICE A DAY) | U | 20235 | BID | |||||||||
127027181 | 12702718 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, DAILY(300 MG IN MORNING AND 300 MG IN NIGHT) | U | 20235 | 600 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127027181 | 12702718 | 1 | Nerve compression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127027181 | 12702718 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127027181 | 12702718 | Burning sensation | |
127027181 | 12702718 | Drug ineffective for unapproved indication | |
127027181 | 12702718 | Electric shock | |
127027181 | 12702718 | Muscle strain | |
127027181 | 12702718 | Nerve injury | |
127027181 | 12702718 | Neuralgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |